Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors

University of Louisville (UOFL)

Status: Completed

Conditions: Breast Cancer

Treatments: Other: bubble packaging for monthly prescription

Study type: Interventional

Funder types: Other

Identifiers

NCT01694225

BCC-BRE-12-Adherence

Details and patient eligibility

About

This study aims to establish the feasibility of using a monthly bubble package to improve compliance rates among women prescribed adjuvant endocrine therapy.

Full description

This study uses Bubble packaging to provide a cost effective way to improve compliance and help direct further interventions to ensure adherence in women on anti-estrogen therapy for breast cancer.

Enrollment: 87 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 years of age or older
• Estrogen receptor positive (> 1% estrogen expression) by immunohistochemistry
• Invasive breast cancer (stage I, II, III) or DCIS considered for adjuvant endocrine therapy

Exclusion criteria

• Patients with metastatic disease (stage IV)
• Patients less than 18 years of age
• Prisoners
• Patients are unable to fill prescriptions at the BCC pharmacy due to insurance limitations or personal preference

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

87 participants in 1 patient group

bubble package for monthly prescription

Experimental group

Description:

use of bubble packaging for monthly prescription

Treatment:

Other: bubble packaging for monthly prescription